StockData
CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Curaleaf Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$7.63−0.20 (-2.55%)

Close on Oct 19, 2026

Market cap
$2.07B
P/E (TTM)
–
Dividend yield
–

About Curaleaf

Medicinal Chemicals & Botanical Products, SIC 2833

Curaleaf Holdings, Inc. operates in the cannabis industry, producing and distributing cannabis and hemp products. The company functions primarily through two operating segments: a domestic segment and an international segment. Its primary commercial operations involve the cultivation, processing, and distribution of cannabis raw materials and finished goods, which generate revenue through retail dispensaries, wholesale transactions, and management services. Curaleaf serves retail consumers through its dispensary network, including adult-use customers, as well as wholesale clients and commercial partners.

The company maintains its principal executive offices in Vancouver, British Columbia, Canada, alongside corporate offices in Stamford, Connecticut. Curaleaf conducts business across North America and Europe, maintaining cultivation facilities, processing sites, and retail dispensaries. Its geographic reach includes operations across multiple United States jurisdictions, such as Arizona, Florida, Massachusetts, New Jersey, New York, and Pennsylvania, alongside international activities in Canada, Germany, Poland, and the United Kingdom.

Summary of the business section of Curaleaf's latest annual report, written by StockData.

Company profile

Company

Legal name
Curaleaf Holdings, Inc.
Headquarters
Stamford, CT
Address
250 Harbor Drive, Third Floor 06902
Phone
(917) 717-5875
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
A1
Fiscal year ends
December 31
Auditor
PKF OConnor Davies, LLP, New York, New York

Stock & identifiers

Ticker
CURLF
Exchange
OTC
Shares outstanding
265M, Jul 27, 2026
Filer category
Large accelerated filer
Stock splits
1-for-3 reverse, Jun 5, 2026; 1-for-3 reverse, Jun 5, 2026
SEC CIK
1756770
CUSIP
23126M300
ISIN
US23126M3007
LEI
529900UBH7GFAVEOKA76
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Curaleaf's leadership is listed in its proxy statement (Form DEF 14A).